Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |